101 results on '"B Lafon"'
Search Results
2. Facteurs de risque d'évolution défavorable des infections de pontage vasculaire plurimicrobiennes
- Author
-
J. Bauer, P. D'elia, J. Sobocinski, A. Boucher, B. Lafon-Desmurs, M. Pradier, A. Meybeck, P. Patoz, E. Senneville, and O. Robineau
- Published
- 2023
3. Staphylococcus aureus CC30 Lineage and Absence of sed,j,r-Harboring Plasmid Predict Embolism in Infective Endocarditis
- Author
-
Jean-Philippe Rasigade, Amélie Leclère, François Alla, Adrien Tessier, Michèle Bes, Catherine Lechiche, Véronique Vernet-Garnier, Cédric Laouénan, François Vandenesch, Catherine Leport, The AEPEI Study Group, B. Hoen, X. Duval, F. Alla, A. Bouvet, S. Briancxon, E. Cambau, M. Celard, C. Chirouze, N. Danchin, T. Doco-Lecompte, F. Delahaye, J. Etienne, B. Iung, V. Le Moing, J. F. Obadia, C. Leport, C. Poyart, M. Revest, C. Selton-Suty, C. Strady, P. Tattevin, F. Vandenesch, Y. Bernard, S. Chocron, P. Plesiat, I. Abouliatim, C. De Place, P. Y. Donnio, J. P. Carteaux, C. Lion, N. Aissa, B. Baehrel, R. Jaussaud, P. Nazeyrollas, V. Vernet, P. Nataf, C. Chidiac, H. Aumaître, J. M. Frappier, E. Oziol, A. Sotto, C. Sportouch, M. Bes, P. Abassade, E. Abrial, C. Acar, J. F. Alexandra, N. Amireche, D. Amrein, P. Andre, M. Appriou, M. A. Arnould, P. Assayag, A. Atoui, F. Aziza, N. Baille, N. Bajolle, P. Battistella, S. Baumard, A. Ben Ali, J. Bertrand, S. Bialek, M. Bois Grosse, M. Boixados, F. Borlot, A. Bouchachi, O. Bouche, S. Bouchemal, J. L. Bourdon, L. Brasme, F. Bricaire, E. Brochet, F. J. Bruntz, A. Cady, J. Cailhol, M. P. Caplan, B. Carette, O. Cartry, C. Cazorla, H. Chamagne, H. Champagne, G. Chanques, J. Chastre, B. Chevalier, F. Chometon, C. Christophe, A. Cohen, N. Colin de Verdiere, V. Daneluzzi, L. David, P. De Lentdecker, V. Delcey, P. Deleuze, E. Donal, B. Deroure, V. Descotes-Genon, K. Didier Petit, A. Dinh, V. Doat, F. Duchene, F. Duhoux, M. Dupont, S. Ederhy, O. Epaulard, M. Evest, J. F. Faucher, B. Fantin, E. Fauveau, T. Ferry, M. Fillod, T. Floch, T. Fraisse, J. M. Frapier, L. Freysz, B. Fumery, B. Gachot, S. Gallien, I. Gandjbach, P. Garcon, A. Gaubert, J. L. Genoud, S. Ghiglione, C. Godreuil, A. Grentzinger, L. Groben, D. Gherissi, P. Gue'ret, A. Hagege, N. Hammoudi, F. Heliot, P. Henry, S. Herson, P. Houriez, L. Hustache-Mathieu, O. Huttin, S. Imbert, S. Jaureguiberry, M. Kaaki, A. Konate, J. M. Kuhn, S. Kural Menasche, A. Lafitte, B. Lafon, F. Lanternier, V. Le Chenault, C. Lechiche, S. Lefèvre-Thibaut, A. Lefort, A. Leguerrier, J. Lemoine, L. Lepage, C. Lepouse', J. Leroy, P. Lesprit, L. Letranchant, D. Loisance, G. Loncar, C. Lorentz, P. Mabo, I. Magnin-Poull, T. May, A. Makinson, H. Man, M. Mansouri, O. Marcxon, J. P. Maroni, V. Masse, F. Maurier, M. C. Meyohas, P. L. Michel, C. Michelet, F. Mechaï, O. Merceron, D. Messika-Zeitoun, Z. Metref, V. Meyssonnier, C. Mezher, S. Micheli, M. Monsigny, S. Mouly, B. Mourvillier, O. Nallet, V. Noel, T. Papo, B. Payet, A. Pelletier, P. Perez, J. S. Petit, F. Philippart, E. Piet, C. Plainvert, B. Popovic, J. M. Porte, P. Pradier, R. Ramadan, J. Richemond, M. Rodermann, M. Roncato, I. Roigt, O. Ruyer, M. Saada, J. Schwartz, M. Simon, B. Simorre, S. Skalli, F. Spatz, J. Sudrial, L. Tartiere, A. Terrier De La Chaise, M. C. Thiercelin, D. Thomas, M. Thomas, L. Toko, F. Tournoux, A. Tristan, J. L. Trouillet, L. Tual, A. Vahanian, F. Verdier, V. Vernet Garnier, V. Vidal, P. Weyne, M. Wolff, A. Wynckel, N. Zannad, and P. Y. Zinzius
- Subjects
S. aureus ,MRSA ,infective endocarditis ,stroke ,CC30 ,enterotoxin ,Microbiology ,QR1-502 - Abstract
Staphylococcus aureus induces severe infective endocarditis (IE) where embolic complications are a major cause of death. Risk factors for embolism have been reported such as a younger age or larger IE vegetations, while methicillin resistance conferred by the mecA gene appeared as a protective factor. It is unclear, however, whether embolism is influenced by other S. aureus characteristics such as clonal complex (CC) or virulence pattern. We examined clinical and microbiological predictors of embolism in a prospective multicentric cohort of 98 French patients with monomicrobial S. aureus IE. The genomic contents of causative isolates were characterized using DNA array. To preserve statistical power, genotypic predictors were restricted to CC, secreted virulence factors and virulence regulators. Multivariate regularized logistic regression identified three independent predictors of embolism. Patients at higher risk were younger than the cohort median age of 62.5 y (adjusted odds ratio [OR] 0.14; 95% confidence interval [CI] 0.05–0.36). S. aureus characteristics predicting embolism were a CC30 genetic background (adjusted OR 9.734; 95% CI 1.53–192.8) and the absence of pIB485-like plasmid-borne enterotoxin-encoding genes sed, sej, and ser (sedjr; adjusted OR 0.07; 95% CI 0.004–0.457). CC30 S. aureus has been repeatedly reported to exhibit enhanced fitness in bloodstream infections, which might impact its ability to cause embolism. sedjr-encoded enterotoxins, whose superantigenic activity is unlikely to protect against embolism, possibly acted as a proxy to others genes of the pIB485-like plasmid found in genetically unrelated isolates from mostly embolism-free patients. mecA did not independently predict embolism but was strongly associated with sedjr. This mecA-sedjr association might have driven previous reports of a negative association of mecA and embolism. Collectively, our results suggest that the influence of S. aureus genotypic features on the risk of embolism may be stronger than previously suspected and independent of clinical risk factors.
- Published
- 2018
- Full Text
- View/download PDF
4. Utilisation de la dalbavancine en traitement suppressif pour les infections de matériels prothétiques
- Author
-
B. Lafon-Desmurs, B. Hennart, B. Valentin, G. Roosen, C. Loiez, E. Beltrand, P. d'Elia, H. Migaud, B. Gachet, and O. Robineau
- Published
- 2023
5. Comment je fais…une transfusion in utero ?
- Author
-
J.-M. Jouannic, A. Mallet, A. Mailloux, Lucie Guilbaud, Ferdinand Dhombres, Paul Maurice, Emeline Maisonneuve, B. Lafon, and A. Cortey
- Subjects
Gynecology ,medicine.medical_specialty ,Reproductive Medicine ,Fetal anemia ,business.industry ,medicine ,Obstetrics and Gynecology ,Intrauterine transfusion ,business - Published
- 2021
6. Connaissances des médecins généralistes en matière de prophylaxie pré-exposition (PrEP) au VIH en 2020
- Author
-
Gilles, M., primary, Tetart, M., additional, Huleux, T., additional, Thill, P., additional, Desmurs, B. Lafon, additional, Meybeck, A., additional, and Robineau, O., additional
- Published
- 2022
- Full Text
- View/download PDF
7. Le haut potentiel intellectuel est-il surreprésenté dans une population de patients douloureux chroniques ?
- Author
-
G. Chatet, C. Plaisant, B. Yvert, D. Suzanne, S. Lorriot, J. Dreneau, and B. Lafon
- Subjects
03 medical and health sciences ,0302 clinical medicine ,Anesthesiology and Pain Medicine ,030204 cardiovascular system & hematology ,030217 neurology & neurosurgery - Abstract
Introduction: Objectif : savoir si le haut potential intellectuel (HPI) favorise l’apparition de douleurs chroniques.Matériel et méthode: Deux tests psychométriques documentent le HPI : l’échelle de vocabulaire Mill Hill pour l’intelligence cristallisée et les matrices progressives standard pour l’intelligence fluide.Résultats: Trente-neuf patients sur 534 sont HPI, soit 7,3 % (versus 2,2 % dans la population générale). Une dysharmonie entre le psychisme et le corps expliquerait ce résultat.
- Published
- 2020
8. Dolutegravir-based dual maintenance regimens combined with lamivudine/emtricitabine or rilpivirine: risk of virological failure in a real-life setting
- Author
-
Caroline Lions, N Biezunski, Sophie Matheron, Romain Guery, Pierre-Marie Roger, Caroline Charlier, Mathieu Dupont, Line Meddeb, Philippe Van de Perre, V Joly, R Lecomte, Matthieu Revest, Claudine Duvivier, B Lefèvre, M Delestan, H Laurichesse, H Marty, F Lemaitre, Martine Valette, Marc-Antoine Valantin, A S Ritleng, A Ménard, Eric Cua, M. Alvarez, A Raoux, M P Bouillon, A Sève, A Brebion, Claire Triffault-Fillit, Sylvie Bregigeon, M Carles, O. Aubry, S Hénard, P. Dellamonica, A Charmillon, E Alidjinou, V Brodard, M Tetart, F Raffi, Paul-Henri Consigny, O Lesens, C Brunet-Cartier, I Lamaury, S Giaché, Amandine Gagneux-Brunon, Jacques Reynes, Karine Sauné, Clotilde Allavena, Q Lepiller, Véronique Reliquet, C Louisin, I Perbost, Jean-Luc Berger, B Prouvost-Keller, Eric Delaporte, Isabelle Lamaury, C Gubavu, L Fagour, Laurent Cotte, G Gaube, Elina Teicher, Faouzi Souala, C Blanc, Dominique Merrien, Isabelle Poizot-Martin, C Drobacheff-Thiébaut, T May, P Richard, M A Trabaud, M Bistoquet, C Klotz, Samira Fafi-Kremer, M Marcel, Charlotte Charpentier, L Lelièvre, K Risso, Sandrine Pierre-François, S Ferrando, S Breaud, S Bevilacqua, A Montoya Ferrer, T Rojas-Rojas, D Boucher, Yazdan Yazdanpanah, Olivier Lortholary, Philippe Colson, Anne-Sophie Brunel, F-Xavier Lescure, Christelle Tomei, M Martin-Degioanni, Eric Rosenthal, Philippe Bossi, Patrick Miailhes, Kevin Bouiller, Lise Cuzin, A Foltzer, F Boulard, Michel Vidal, V Mondain, H Colson, J Pasquier, I Kmiec, F Alby-Laurent, R Agher, A Cabié, Guillaume Martin-Blondel, L Hocqueloux, M Colin, A Madrid, Faiza Ajana, J M Livrozet, V Rio, Karima Amazzough, C Merle de Boever, M Digumber, Thomas Perpoint, A Cheret, Laurence Bocket, Z Julia, Virginie Ferré, M Pradier, M Poisson-Vannier, A Legoff, M J Soavi, Y Quertainmont, Marine Morrier, Christian Chidiac, F Touam, O Zaegel-Faucher, A Marquise, G Benabdelmoumen, Florence Ader, T Guimard, M C Receveur, J C Tardy, P Morineau, K Guitteaud, D. Rey, S Leautez, Catherine Chirouze, Benoit Tressières, A. Ivanova, C Charre, J Reynes, Christian Pradier, Catherine Dhiver, Laurent Boyer, E Frentiu, David Rey, C Allavena, Anne Motte, Tristan Ferry, C Pronier, M. Hentzien, C Rouzaud, O Cabras, K Jidar, F Najioullah, C Clavel, M Orticoni, S Patrat-Delon, M Cavellec, Cécile Herrmann-Storck, V Baclet, Jade Ghosn, M Perry, S Wehrlen-Pugliese, J. M. Chapplain, R Palich, Laurent Hocqueloux, A Maillard, C Deschanvres, O Deradji, F. Lucht, A Grégoire, Veronique Joly, R Ouissa, C Daniel, N Mrozek, D Chirio, O Bollangier, J Bavay, P. Le Turnier, A Maka, C Rioux, Colin Deschanvres, C Brochier, Elisabeth Botelho-Nevers, A Meybeck, C Ceppi, J Lourenco, François Bénézit, Thomas Jovelin, G Zouzou, N Tissot, N. Viget, F Brunel-Dalmas, Brigitte Montes, N Chellum Rungen, K Rome, David Boutoille, B Bigeard, I Fabre, N Oran, M Lefebvre, P Point, C Etienne, Diane Descamps, G Thomas, S Le Gac, Cyrille Delpierre, Pierre Tattevin, M Godinot, P Fischer, C Aumeran, C Boulard, Elisabeth André-Garnier, J Sinteff, V Ronat, F Goehringer, Romain Palich, Luminita Schneider, I Touitou, Eric Billaud, P Thill, Catherine Varache, Olivier Robineau, I Jaquet, Roland Landman, Cédric Arvieux, B. Bonnet, V Rzepecki, Olivier Grossi, Christian Rabaud, L Laine, F Louni, C Cheneau, S Markowicz, Hélène Laroche, A Gervais, C Bernard-Henry, E Goncalvez, N Lerolle, M André, D Lambert, André Boibieux, L. Porte, S Bouchez, E Paredes, E Aïssi, V. Le Moing, S Degroodt, Sylvie Abel, André Cabié, B Lafon-Desmurs, O Babre, M Baldeyrou, C Debreux, A Rodallec, Pierre Delobel, V Icard, Agathe Becker, Edouard Tuaillon, Hervé Tissot-Dupont, M Mokhtari, C Morlat, I Alcaraz, Anne Frésard, O Cannesson, Elodie Curlier, P Chiarello, S. Roux, F Bani-Sadr, François Raffi, Florent Valour, M Piffaut, M Priester, A. Belkhir, J Romaru, Cécile Goujard, A Castro, G Cessot, A Mirand, C Pouderoux, A Brunet, C Michelangeli, Y N’guyen, Patrice Muret, Elisa Demonchy, Christine Jacomet, D Makhloufi, E Jeanmaire, Marialuisa Partisani, Véronique Obry-Roguet, J Turmel, C Mélounou, J. Durant, Christine Katlama, P Parize, O Robineau, S Seang, F. Bozon, S Galie, Alexa Debard, E de Mautort, C Duvivier, Fanny Lanternier, Alain Makinson, A Barrail-Tran, C Aguilar, A Naqvi, Rodolphe Garraffo, N Meftah, C Biron, A de Monte, Pascal Pugliese, V Corbin, S Jaureguiberry, E Lafont, L Hustache Mathieu, R Colarino, Isabelle Ravaux, C Henquell, Benoit Pilmis, M Grégoire, P Lansalot, E Ressiot, T. Huleux, Olivier Baud, S Sécher, R Dupin de Majoubert, J Leporrier, L Cuzin, E Chevalier, M Poinot, R Tubiana, S Lariven, A Boucher, N Atoui, Firouzé Bani-Sadr, T Prazuck, M Ducassou, Gilles Peytavin, A Soria, B J Gaborit, Service des maladies infectieuses et tropicales [CHU Nantes], Centre hospitalier universitaire de Nantes (CHU Nantes), Dat’AIDS Study Group, Département Maladies Infectieuses et Tropicales, Hôpital Universitaire, Montpellier, France, Centre Hospitalier Régional Universitaire [Montpellier] (CHRU Montpellier), Recherches Translationnelles sur le VIH et les maladies infectieuses endémiques et émergentes (TransVIHMI), Institut de Recherche pour le Développement (IRD)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Université de Montpellier (UM), CHU Pointe-à-Pitre/Abymes [Guadeloupe], Les Hôptaux universitaires de Strasbourg (HUS), CHU Strasbourg, CHU Pitié-Salpêtrière [AP-HP], Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Sorbonne Université (SU), Centre Hospitalier Universitaire de Reims (CHU Reims), Centre Hospitalier Gustave Dron [Tourcoing], Institut Pasteur [Paris] (IP), Centre Hospitalier Régional d'Orléans (CHRO), Centre d'Epidémiologie et de Recherche en santé des POPulations (CERPOP), Université Toulouse III - Paul Sabatier (UT3), Université de Toulouse (UT)-Université de Toulouse (UT)-Institut National de la Santé et de la Recherche Médicale (INSERM), CHU de la Martinique [Fort de France], AP-HP - Hôpital Bichat - Claude Bernard [Paris], Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP), Centre Hospitalier Universitaire de Martinique [Fort-de-France, Martinique], CHU Clermont-Ferrand, and Université Clermont Auvergne (UCA)
- Subjects
Microbiology (medical) ,medicine.medical_specialty ,Anti-HIV Agents ,Pyridones ,MESH: Piperazines ,HIV Infections ,Emtricitabine ,Piperazines ,law.invention ,chemistry.chemical_compound ,Randomized controlled trial ,law ,[SDV.MHEP.MI]Life Sciences [q-bio]/Human health and pathology/Infectious diseases ,Internal medicine ,MESH: Pyridones ,Oxazines ,MESH: Emtricitabine ,Humans ,Medicine ,Pharmacology (medical) ,MESH: Anti-HIV Agents ,Pharmacology ,MESH: Heterocyclic Compounds, 3-Ring ,MESH: Humans ,business.industry ,Rilpivirine ,Lamivudine ,MESH: HIV Infections ,Viral Load ,[SDV.SP]Life Sciences [q-bio]/Pharmaceutical sciences ,Virological failure ,Regimen ,Infectious Diseases ,chemistry ,[SDV.MP.VIR]Life Sciences [q-bio]/Microbiology and Parasitology/Virology ,Dolutegravir ,Cohort ,MESH: Rilpivirine ,business ,MESH: Viral Load ,Heterocyclic Compounds, 3-Ring ,MESH: Oxazines ,medicine.drug ,MESH: Lamivudine - Abstract
Background Maintenance ART with dolutegravir-based dual regimens have proved their efficacy among HIV-1-infected subjects in randomized trials. However, real-life data are scarce, with limited populations and follow-up. Objectives We assessed virological failure (VF) and resistance-associated mutations (RAMs) on dolutegravir maintenance regimens in combination with rilpivirine or with lamivudine or emtricitabine (xTC) and analysed the factors associated with VF. Methods Between 2014 and 2018, all HIV-1-infected adults included in the Dat’AIDS cohort and starting dolutegravir/rilpivirine or dolutegravir/xTC as a maintenance dolutegravir-based dual regimen were selected. VF was defined as two consecutive HIV RNA values >50 copies/mL or a single value >400 copies/mL. We compared cumulative genotypes before initiation of a maintenance dolutegravir-based dual regimen with genotype at VF. Results We analysed 1374 subjects (799 on dolutegravir/rilpivirine and 575 on dolutegravir/xTC) with a median follow-up of 20 months (IQR = 11–31) and 19 months (IQR = 11–31), respectively. VF occurred in 3.8% (n = 30) of dolutegravir/rilpivirine subjects and 2.6% (n = 15) of dolutegravir/xTC subjects. Among subjects receiving dolutegravir/rilpivirine, two genotypes harboured emerging RAMs at VF: E138K on NNRTI (n = 1); and E138K+K101E on NNRTI and N155H on INSTI (n = 1). Among subjects receiving dolutegravir/xTC, no new RAM was detected. The only predictive factor of VF on dolutegravir/rilpivirine was the history of failure on an NNRTI-based regimen (adjusted HR = 2.97, 95% CI = 1.28–6.93). No factor was associated with VF on dolutegravir/xTC. Conclusions In this large real-life cohort, dolutegravir/rilpivirine and dolutegravir/xTC sustained virological suppression and were associated with a low rate of VF and RAM emergence. Careful virological screening is essential before switching to dolutegravir/rilpivirine in virologically suppressed patients with a history of NNRTI therapy.
- Published
- 2022
9. Diagnostic prénatal et issue néonatale des calcifications intra-abdominales isolées : étude rétrospective sur 10 ans
- Author
-
J.-M. Jouannic, B. Lafon, Ferdinand Dhombres, Gilles Kayem, Catherine Garel, L. Debain, Emeline Maisonneuve, E. Hervieux, Département Médico-Universitaire Obstétrique reproduction Infertilité Gynécologie Enfants (DMU ORIGYNE Femmes-Mères-Enfants), CHU Charles Foix [AP-HP], Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Sorbonne Université (SU)-Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Sorbonne Université (SU)-CHU Tenon [AP-HP], Sorbonne Université (SU)-Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-CHU Pitié-Salpêtrière [AP-HP], Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Sorbonne Université (SU)-CHU Trousseau [APHP], Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Sorbonne Université (SU)-CHU Rothschild [AP-HP], Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Sorbonne Université (SU)-CHU Saint-Antoine [AP-HP], Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Sorbonne Université (SU), Sorbonne Université - Faculté de Médecine (SU FM), and Sorbonne Université (SU)
- Subjects
Gynecology ,medicine.medical_specialty ,030219 obstetrics & reproductive medicine ,business.industry ,[SDV]Life Sciences [q-bio] ,Obstetrics and Gynecology ,Prenatal diagnosis ,3. Good health ,03 medical and health sciences ,0302 clinical medicine ,Reproductive Medicine ,Medicine ,030212 general & internal medicine ,Ultrasonography ,business ,Fetal medicine - Abstract
Resume Objectifs Les calcifications intra-abdominales (iA) retrouvees lors d’une echographie obstetricale peuvent etre isolees ou associees a d’autres anomalies. Notre objectif etait d’etudier tous les cas de calcifications iA isolees echographiquement pris en charge dans notre centre, en decrivant leur localisation precise, leur bilan etiologique et l’issue neonatale associee. Methodes Nous avons realise une etude monocentrique retrospective descriptive sur les nouveau-nes ayant eu un diagnostic de calcification iA isolee en echographie de reference antenatale ainsi qu’un avis au centre pluridisciplinaire de diagnostic prenatal a l’hopital Trousseau et nes entre le 1er janvier 2008 et le 30 juin 2018. Les criteres d’exclusion etaient : les calcifications retro-peritoneales, les calcifications iA associees a des anomalies digestives ou autres malformations congenitales. Resultats Les 32 cas de calcifications iA isolees representaient 46 % de toutes les calcifications iA. Apres exclusion de 9 dossiers pour donnees neonatales manquantes, parmi les 23 cas de calcifications isolees, 15 concernaient des calcifications hepatiques, 5 des peri-hepatiques et 2 des peritoneales. Un fœtus etait porteur a la fois de calcifications intra- et peri-hepatiques. La majorite des calcifications sont restees stables tout au long de la grossesse. Aucun cas d’aneuploidie, de fœtopathie infectieuse, ni de mucoviscidose n’a ete retrouve. L’issue neonatale de tous ces enfants a ete favorable. Conclusions En cas de calcification iA paraissant isolee apres echographie de reference et stable sur plusieurs echographies, apres avoir elimine une fœtopathie infectieuse et recherche les mutations les plus frequentes de la mucoviscidose chez les parents, le pronostic est favorable.
- Published
- 2019
10. Incidence of diabetes in HIV-infected patients treated with first-line integrase strand transfer inhibitors: a French multicentre retrospective study
- Author
-
P Fischer, C Aumeran, V Ronat, L Laine, S Bouchez, André Cabié, D Lambert, Eric Cua, J Pasquier, F Touam, Laurent Hocqueloux, A Maillard, O Deradji, Charlotte Charpentier, Véronique Avettand-Fenoel, Catherine Tamalet, Anne Frésard, Elodie Curlier, M Batard, S Ferrando, S Breaud, Philippe Bossi, C Pronier, C Gubavu, M Martin-Degiovani, Samira Fafi-Kremer, A. Duréault, Christian Pradier, A Montoya Ferrer, M Piffaut, Faiza Ajana, V Rio, A Maka, C Biron, Pierre Delobel, A de Monte, P Choisy, L Lelièvre, K Risso, N. Viget, Q Lepiller, Véronique Reliquet, I Perbost, Laurence Bocket, C Rioux, G Thomas, O. Aubry, L. Porte, Cédric Arvieux, Thomas Jovelin, Elisabeth Botelho-Nevers, Pierre-Marie Roger, C Etienne, David Boutoille, S Le Gac, Caroline Charlier, Virginie Ferré, M Pradier, M C Receveur, Isabelle Ravaux, Philippe Colson, K Rome, O Lesens, C Brunet-Cartier, A Meybeck, Romain Palich, P Martinet, V. Le Moing, C Ceppi, Hélène Laroche, I Lamaury, V Brodard, N Oran, M Lefebvre, P Morineau, K Guitteaud, M Bistoquet, Diane Descamps, O Cabras, Amandine Gagneux-Brunon, Brigitte Montes, Olivier Robineau, I Jaquet, Roland Landman, C Cheneau, V Mondain, Caroline Lions, Olivier Grossi, Laurent Boyer, C Debreux, M André, A Rodallec, Philippe Van de Perre, Jade Ghosn, Clotilde Allavena, Sylvie Abel, Karine Sauné, F Louni, F Boulard, Luminita Schneider, Dominique Merrien, D Chirio, S Pillet, Mathieu Dupont, A Motte, F Lemaitre, C Guennoun, Benoît Henry, S Sausse, Michel Vidal, M Mokhtari, O Zaegel-Faucher, Eric Rosenthal, Isabelle Poizot-Martin, Faouzi Souala, Matthieu Revest, M Baldeyrou, S Patrat-Delon, Jacques Reynes, M Cavellec, Laurent Cotte, C Michelangeli, François Danion, M Priester, Axel Ursenbach, C Mackoumbou-Nkouka, Thomas Perpoint, A Cheret, P Geneau de Lamarlière, Christian Rabaud, Agathe Becker, Tristan Ferry, A. Ivanova, Elina Teicher, T Bonijoly, F-Xavier Lescure, O Bollangier, A S Ritleng, Patrick Miailhes, A Gervais, Y N’guyen, Patrice Muret, Elisa Demonchy, Vincent Max, I Alcaraz, N Meftah, M P Bouillon, S Degroodt, A Foltzer, Laurent Hustache-Mathieu, Jean-Luc Berger, A Ménard, J Prouteau, B. Bonnet, Kevin Bouiller, Lise Cuzin, Christian Chidiac, R Agher, S Leautez, Catherine Chirouze, M Poinot, R Tubiana, E Aïssi, O Babre, J Lourenco, Benoit Tressières, C Clavel, Cécile Goujard, A Brunet, Claire Triffault-Fillit, F Raffi, E Sidani, Anne-Sophie Brunel, A Madrid, B Prouvost-Keller, Eric Delaporte, M J Soavi, J. M. Chapplain, M Orticoni, Pascal Pugliese, V Corbin, Pierre Tattevin, C Boulard, Véronique Obry-Roguet, P. Loubet, Paul-Henri Consigny, Elisabeth André-Garnier, J Sinteff, S Lariven, A Boucher, N Lerolle, C Blanc, Y Quertainmont, Sylvie Bregigeon, Bruno Hoen, André Boibieux, S Casanova, N Atoui, C Dhiver, N Biezunski, R Ouissa, M. Hentzien, C Bernard-Henry, Sophie Matheron, Cécile Herrmann-Storck, Firouzé Bani-Sadr, I Touitou, Eric Billaud, I Kmiec, Benoit Pilmis, T Prazuck, Romain Guery, Karima Amazzough, C Merle de Boever, Marine Morrier, T Guimard, M Poisson-Vanier, H Laurichesse, Catherine Varache, J Goesch, Guillaume Martin-Blondel, Z Julia, M Ducassou, F. Lucht, B Lafon-Desmurs, Martine Valette, A Sève, Marc-Antoine Valantin, G Zouzou, A Barrail-Tran, M Delestan, M. Alvarez, A Naqvi, Colin Deschanvres, A Raoux, L Meddeb, Rodolphe Garraffo, C Daniel, T May, A. Galinier, François Bénézit, Yazdan Yazdanpanah, Veronique Joly, Olivier Lortholary, C Louisin, K Jidar, I Fabre, Cyrille Delpierre, Christine Katlama, P Parize, S Galie, Claudine Duvivier, P. Dellamonica, L Osei, C Drobacheff-Thiébaut, Sandrine Pierre-François, G Cessot, C. Tomei, F. Biron, Christine Jacomet, G Benabdelmoumen, Florence Ader, David Rey, Marialuisa Partisani, J Turmel, J. Durant, S Seang, F. Bozon, M Illiaquer, N Hall, Edouard Tuaillon, S. Roux, Florent Valour, A. Belkhir, Marine Maurel, V Baclet, N Mrozek, Olivier Baud, S Sécher, P Letertre-Gibert, Alexa Debard, E de Mautort, Fanny Lanternier, Alain Makinson, H. Tissot Dupont, P Lansalot, E Ressiot, T. Huleux, S Wehrlen-Pugliese, M Landon, C Brochier, C Bernaud, Gilles Peytavin, A Soria, Institut Hospitalier Universitaire Méditerranée Infection (IHU Marseille), Centre Hospitalier Régional Universitaire [Montpellier] (CHRU Montpellier), Recherches Translationnelles sur le VIH et les maladies infectieuses endémiques er émergentes (TransVIHMI), Université Cheikh Anta Diop [Dakar, Sénégal] (UCAD)-Institut de Recherche pour le Développement (IRD)-Université de Yaoundé I-Institut National de la Santé et de la Recherche Médicale (INSERM)-Université de Montpellier (UM)-Université Montpellier 1 (UM1), Département Maladies Infectieuses et Tropicales, Hôpital Universitaire, Montpellier, France, Pathogénèse et contrôle des infections chroniques (PCCI), Institut National de la Santé et de la Recherche Médicale (INSERM)-Université de Montpellier (UM)-Centre Hospitalier Universitaire de Montpellier (CHU Montpellier ), Service de pharmacologie, Hôpital Pasteur [Nice] (CHU)-Centre Hospitalier Universitaire de Nice (CHU Nice), Centre Hospitalier Universitaire de Reims (CHU Reims), Laboratoire de Virologie Médicale et Moléculaire - EA 4684 (CardioVir), Université de Reims Champagne-Ardenne (URCA)-SFR CAP Santé (Champagne-Ardenne Picardie Santé), Université de Reims Champagne-Ardenne (URCA)-Université de Picardie Jules Verne (UPJV)-Université de Reims Champagne-Ardenne (URCA)-Université de Picardie Jules Verne (UPJV)-Centre Hospitalier Universitaire de Reims (CHU Reims), Groupe Immunité des Muqueuses et Agents Pathogènes (GIMAP), Université Jean Monnet [Saint-Étienne] (UJM), School of Civil and Environmental Engineering [Sydney], University of New South Wales [Sydney] (UNSW), Institut Pierre Louis d'Epidémiologie et de Santé Publique (iPLESP), Institut National de la Santé et de la Recherche Médicale (INSERM)-Sorbonne Université (SU), Laboratoire Chrono-environnement - CNRS - UFC (UMR 6249) (LCE), Centre National de la Recherche Scientifique (CNRS)-Université de Franche-Comté (UFC), Université Bourgogne Franche-Comté [COMUE] (UBFC)-Université Bourgogne Franche-Comté [COMUE] (UBFC), Centre Hospitalier Régional Universitaire [Besançon] (CHRU Besançon), Pathologies Pulmonaires et Plasticité Cellulaire - UMR-S 1250 (P3CELL), and Université de Reims Champagne-Ardenne (URCA)-Institut National de la Santé et de la Recherche Médicale (INSERM)
- Subjects
0301 basic medicine ,Microbiology (medical) ,Adult ,medicine.medical_specialty ,[SDV]Life Sciences [q-bio] ,Integrase inhibitor ,HIV Infections ,HIV Integrase ,Diabetes Therapy ,Cohort Studies ,03 medical and health sciences ,chemistry.chemical_compound ,0302 clinical medicine ,[SDV.MHEP.MI]Life Sciences [q-bio]/Human health and pathology/Infectious diseases ,Internal medicine ,Diabetes mellitus ,medicine ,Diabetes Mellitus ,Humans ,Pharmacology (medical) ,030212 general & internal medicine ,HIV Integrase Inhibitors ,ComputingMilieux_MISCELLANEOUS ,Retrospective Studies ,Pharmacology ,Integrases ,business.industry ,Incidence ,Retrospective cohort study ,Raltegravir ,medicine.disease ,Comorbidity ,3. Good health ,030104 developmental biology ,Infectious Diseases ,chemistry ,Dolutegravir ,business ,medicine.drug ,Cohort study - Abstract
BackgroundIntegrase strand transfer inhibitors (INSTIs) are increasingly used in patients living with HIV due to their safety, effectiveness and high genetic barrier. However, an association with weight gain has recently been suggested and several cases of diabetes mellitus have been reported with raltegravir and dolutegravir. The long-time metabolic impact of these recent molecules remains unclear.ObjectivesTo assess if an INSTI as a third agent is statistically associated with new-onset diabetes mellitus compared with an NNRTI or a PI.Patients and methodsPatients undergoing first-line combined ART (cART) without diabetes at baseline were retrospectively included from the Dat’AIDS French cohort study (ClinicalTrials.gov NCT02898987). Incident diabetes mellitus was defined as a notification of new diabetes in the medical history, a glycated haemoglobin (HbA1c) level superior to 7.5% or the start of a diabetes therapy following the initiation of ART.ResultsFrom 2009 to 2017, 19 462 patients were included, among which 265 cases of diabetes mellitus occurred. Multivariate and survival analyses did not highlight an increase in new-onset diabetes in patients undergoing cART with an INSTI as a third agent compared with an NNRTI or a PI. BMI >30 kg/m2, age >37 years old (in survival analysis), black race or Hispanic ethnicity, arterial hypertension and AIDS were associated with a higher proportion of incident diabetes.ConclusionsINSTIs were not statistically associated with new-onset diabetes. However, clinicians should remain aware of this possible metabolic comorbidity, particularly in patients with a high BMI and older patients.
- Published
- 2020
11. Reaching the Second and Third Joint United Nations Programme on Human Immunodeficiency Virus (HIV)/AIDS 90-90-90 Targets Is Accompanied by a Dramatic Reduction in Primary HIV Infection and in Recent HIV Infections in a Large French Nationwide HIV Cohort
- Author
-
Claudine Duvivier, Clotilde Allavena, J Lippmann, P. Dellamonica, A Soria, Sandrine Pierre-François, B J Gaborit, Isabelle Poizot-Martin, Anne Frésard, Elodie Curlier, F. Biron, Eric Cua, M Saadia Mokhtari, I Luquet Besson, C Gubavu, Caroline Lions, Laurent Cotte, C. Tomei, Elina Teicher, Faouzi Souala, Karima Amazzough, C Merle de Boever, Romain Palich, C Brochier, Véronique Reliquet, Patrick Miailhes, M Priester, Samira Fafi-Kremer, Mathieu Dupont, M Piffaut, I. Schlienger, C Bernaud, A S Ritleng, F-Xavier Lescure, C Cheneau, L Lelièvre, C Biron, Adrien Le Guillou, Alexa Debard, Marc-Antoine Valantin, Gilles Peytavin, S Lariven, G Benabdelmoumen, Florence Ader, I Kmiec, I Fabre, Cyrille Delpierre, C. Longuet, François Raffi, A de Monte, M. Alvarez, David Rey, A Boucher, M. Valette, E de Mautort, Jean-Luc Berger, H Bertone, Bruno Hoen, M Poisson-Vanier, Pascal Pugliese, Virginie Ferré, M Pradier, Z Julia, Nathalie Dournon, M Baldeyrou, N Biezunski, Caroline Charlier, J Goesch, J Pasquier, M P Bouillon, Cécile Goujard, Sophie Matheron, V. Le Moing, Romain Guery, N. Viget, N Atoui, C Dhiver, A Meybeck, Fanny Lanternier, F Touam, Tristan Ferry, M Carta Padovani, G Thomas, C Ceppi, A Brunet, Alain Makinson, Isabelle Ravaux, Laurent Hocqueloux, A Maillard, Firouzé Bani-Sadr, P. Loubet, Laurent Boyer, O Deradji, I Alcaraz, T Prazuck, A Rodallec, F Lemaitre, B Lafon-Desmurs, J Turmel, A Sève, Benoit Pilmis, A Gervais, C. Augustin-Normand, D Chirio, Brigitte Montes, Cédric Arvieux, V Brodard, M Delestan, E Aïssi, C Louisin, Christian Chidiac, M Ducassou, S Leautez, Catherine Chirouze, M André, Dominique Merrien, Q Gardiennet, P Fischer, Sylvie Abel, Guillaume Martin-Blondel, Benoît Henry, H. Tissot Dupont, S Patrat-Delon, A Ménard, E. Billaud, Malikhone Chansombat, K Jidar, Karine Sauné, Colin Deschanvres, V. Gueripel, M Cavellec, K. Schepers, C Pronier, R Ouissa, P Choisy, A Cheret, A. Belkhir, P Parize, A Barrail-Tran, B. Bonnet, C Mackoumbou-Nkouka, A. Galinier, M Monclar, P Lansalot, S Bouchez, C Guennoun, N Meftah, C Brunet-Cartier, Pierre Tattevin, J. Durant, E Ressiot, T. Huleux, François Bénézit, C Boulard, M Poinot, Elisabeth André-Garnier, J Sinteff, André Cabié, Charlotte Charpentier, L Meddeb, Rodolphe Garraffo, M Batard, D. Lebrun, R Tubiana, M J Soavi, I Lamaury, Philippe Bossi, Y Quertainmont, S Galie, C Michelangeli, François Danion, N Lerolle, Y N’guyen, Amandine Gagneux-Brunon, Elisa Demonchy, Christine Katlama, C Bernard-Henry, V Mondain, S Seang, David Boutoille, P. Le Turnier, Faiza Ajana, André Boibieux, J Koffi, L. Porte, Laurence Bocket, O Bollangier, A Maka, S Sécher, Marine Morrier, T Guimard, Matthieu Revest, C Godard, C Rioux, C Etienne, M Illiaquer, O. Aubry, N Hall, Paul-Henri Consigny, C Blanc, P Morineau, K Guitteaud, T. Perpoint, G Cessot, V Baclet, Lise Cuzin, T May, E Braun, Marialuisa Partisani, Veronique Joly, Jacques Reynes, Olivier Lortholary, C Blanco-Betancourt, Philippe Van de Perre, D Lambert, Moustapha Dramé, S Ferrando, S Breaud, A Montoya Ferrer, Yazdan Yazdanpanah, M. Hentzien, Cécile Herrmann-Storck, A. Duréault, A. Ivanova, F. Lucht, Pierre Delobel, Thomas Jovelin, J. M. Chapplain, Olivier Robineau, Roland Landman, Olivier Grossi, F Louni, Elisabeth Botelho-Nevers, J Lourenco, M Lefebvre, Diane Descamps, Luminita Schneider, R Agher, M Orticoni, D Rahli, S Degroodt, CHU de la Martinique [Fort de France], Centre Hospitalier Universitaire de Nice (CHU Nice), Service de maladies infectieuses et tropicales [Nantes], Université de Nantes (UN)-Hôtel-Dieu-Centre hospitalier universitaire de Nantes (CHU Nantes), Department of Infectious Diseases [Nantes], Hôtel-Dieu de Nantes, Institut Pierre Louis d'Epidémiologie et de Santé Publique (iPLESP), Institut National de la Santé et de la Recherche Médicale (INSERM)-Sorbonne Université (SU), Infectious Diseases and Tropical Medicine Unit [Fort-de-France, Martinique], Centre Hospitalier Universitaire de Reims (CHU Reims), Laboratoire de Virologie Médicale et Moléculaire - EA 4684 (CardioVir), Université de Reims Champagne-Ardenne (URCA)-Centre Hospitalier Universitaire de Reims (CHU Reims)-SFR CAP Santé (Champagne-Ardenne Picardie Santé), Université de Reims Champagne-Ardenne (URCA)-Université de Picardie Jules Verne (UPJV)-Université de Reims Champagne-Ardenne (URCA)-Université de Picardie Jules Verne (UPJV), Département de maladies infectieuses, and Hospices Civils de Lyon (HCL)
- Subjects
0301 basic medicine ,Microbiology (medical) ,Cart ,medicine.medical_specialty ,Longitudinal study ,business.industry ,Public health ,Incidence (epidemiology) ,medicine.disease ,030112 virology ,3. Good health ,03 medical and health sciences ,0302 clinical medicine ,Infectious Diseases ,Acquired immunodeficiency syndrome (AIDS) ,Interquartile range ,[SDV.MHEP.MI]Life Sciences [q-bio]/Human health and pathology/Infectious diseases ,Internal medicine ,Epidemiology ,Cohort ,Medicine ,030212 general & internal medicine ,business - Abstract
Background In late 2013, France was one of the first countries to recommend initiation of combination antiretroviral therapy (cART) irrespective of CD4 cell count. Methods To assess the impact of achieving the second and third Joint United Nations Programme on HIV/AIDS 90-90-90 targets (ie, 90% of diagnosed people on sustained cART, and, of those, 90% virologically controlled) on human immunodeficiency virus (HIV) incidence, we conducted a longitudinal study to describe the epidemiology of primary HIV infection (PHI) and/or recent HIV infection (patients with CD4 cell count ≥500/mm3 at HIV diagnosis; (PRHI) between 2007 and 2017 in a large French multicenter cohort. To identify changes in trends in PHI and PRHI, we used single breakpoint linear segmented regression analysis. Results During the study period, 61 822 patients were followed in the Dat’AIDS cohort; 2027 (10.0%) had PHI and 7314 (36.1%) had PRHI. The second and third targets were reached in 2014 and 2013, respectively. The median delay between HIV diagnosis and cART initiation decreased from 9.07 (interquartile range [IQR], 1.39–33.47) months in 2007 to 0.77 (IQR, 0.37–1.60) months in 2017. A decrease in PHI (−35.1%) and PRHI (−25.4%) was observed starting in 2013. The breakpoints for PHI and PRHI were 2012.6 (95% confidence interval [CI], 2010.8–2014.4) and 2013.1 (95% CI, 2011.3–2014.8), respectively. Conclusions Our findings show that the achievements of 2 public health targets in France and the early initiation of cART were accompanied by a reduction of about one-third in PHI and PRHI between 2013 and 2017. Clinical Trials Registration NCT02898987.
- Published
- 2020
12. [How I do…an intrauterine transfusion?]
- Author
-
L, Guilbaud, E, Maisonneuve, P, Maurice, F, Dhombres, B, Lafon, A, Mallet, A, Mailloux, A, Cortey, and J-M, Jouannic
- Subjects
Pregnancy ,Blood Transfusion, Intrauterine ,Humans ,Anemia ,Female ,Retrospective Studies - Published
- 2020
13. Sequential disseminated aspergillosis and pulmonary tuberculosis in a patient treated by idelalisib for chronic lymphocytic leukemia
- Author
-
S. Jauréguiberry, A. Fekkar, Eric Caumes, B. Lafon-Desmurs, V. Leblond, G. Monsel, and M. Papo
- Subjects
Tuberculosis ,Chronic lymphocytic leukemia ,Antineoplastic Agents ,Aspergillosis ,03 medical and health sciences ,0302 clinical medicine ,Pharmacotherapy ,B-cell chronic lymphocytic leukaemia ,Pulmonary tuberculosis ,medicine ,Humans ,030212 general & internal medicine ,Tuberculosis, Pulmonary ,Quinazolinones ,business.industry ,Middle Aged ,medicine.disease ,Leukemia, Lymphocytic, Chronic, B-Cell ,Disseminated aspergillosis ,Infectious Diseases ,Purines ,030220 oncology & carcinogenesis ,Immunology ,Female ,business ,Idelalisib - Published
- 2017
14. [Prenatal diagnosis and postnatal outcome of isolated intra-abdominal calcifications: A 10-year experience from a referral fetal medicine center]
- Author
-
E, Maisonneuve, L, Debain, C, Garel, E, Hervieux, B, Lafon, F, Dhombres, G, Kayem, and J-M, Jouannic
- Subjects
Cystic Fibrosis ,Liver Diseases ,Infant, Newborn ,Pregnancy Outcome ,Calcinosis ,Aneuploidy ,Infections ,Peritoneal Diseases ,Ultrasonography, Prenatal ,Fetal Diseases ,Pregnancy ,Humans ,Female ,Retrospective Studies - Abstract
Intra-abdominal calcifications (iAC) detected during fetal ultrasound examinations are characterized by their isolated or associated nature, as well as their location. Our objective was to describe all cases of isolated iAC along with their etiological investigations and neonatal outcome, during a 10-year practice in a referral center.We conducted a retrospective descriptive monocentric study on neonates diagnosed with isolated iAC after antenatal expert ultrasound scan and referred to the Multidisciplinary Center for Prenatal Diagnosis at Trousseau Hospital and born between January 1st, 2008 and June 30th, 2018. The exclusion criteria were: retroperitoneal calcifications, iAC associated with other digestive abnormalities or with congenital malformations.The 32 isolated iAC cases accounted for 46% of all iAC. Nine cases were excluded for missing neonatal data. Among the 23 remaining isolated iAC cases, we observed 15 intra-hepatic calcifications, 5 peri-hepatic and two peritoneal calcifications. One fetus had both intra- and peri-hepatic calcifications. The majority of iAC remained stable throughout pregnancy. No cases of aneuploidy, fetal infection, or cystic fibrosis were detected. The neonatal outcome was favorable in all cases.In case of isolated and stable iAC after expert ultrasound scan, after having ruled out infectious diseases of the fetus and looked for the most frequent mutations of cystic fibrosis in the parents, the prognosis is favorable. Fetal karyotyping is recommended when additional structural anomalies are present.
- Published
- 2019
15. Intérêt de la tomographie par émission de positons (TEP) dans le diagnostic et le suivi des infections de prothèses vasculaires (IPV)
- Author
-
Olivier Leroy, A. Boucher, Piervito D’Elia, Olivier Robineau, A. Pasquet, S. Vandamme, B. Lafon-Desmurs, and Eric Senneville
- Subjects
Infectious Diseases - Abstract
Introduction Les IPV sont une complication rare mais severe car associee a une importante mortalite et un fort taux d’amputation. Leur diagnostic et leur suivi n’est pas aise ni consensuel par les moyens cliniques, biologiques et radiologiques standards. L’objectif de cette etude est d’evaluer l’interet de la TEP dans le diagnostic et le suivi des patients avec une IPV. Materiels et methodes Tous les patients diagnostiques avec une IPV et ayant beneficie d’au moins une TEP entre le moment du diagnostic et le suivi, entre janvier 2006 et decembre 2019 ont ete inclus dans l’etude. Les IPV etaient divisees en extra-cavitaires (femoro-femorales, femoro-poplitees et axillo-femorales) et cavitaires (aorto-iliaques, aorto-femorales, ilio-femorales, aortiques) et classees en IPV precoces (≤ 4 mois postoperatoires) ou IPV tardives (> 4 mois postoperatoires). Resultats Un total de 230 patients a ete diagnostique pour une IPV comprenant 70 (30 %) ayant beneficie d’au moins une TEP. La moyenne d’âge de ces derniers, etait de 68,5 ans. L’obesite etait presente chez 52 d’entre eux (74 %) et une hypercholesteromie chez 46 d’entre eux (68 %). Les IPVs tardives representaient 27 infections (39 %). Staphylococcus aureus a ete documente chez 26 patients (37 %). La documentation microbiologique etait plurimicrobienne dans 25 cas (36 %). Chez ces 70 patients ayant beneficie d’au moins une TEP, 33 (47 %) etaient realisees dans le cadre du diagnostic initial dont 23 (70 %) etaient en faveur d’une IPV. Une deuxieme et une troisieme TEP ont ete realisees respectivement pour 24 (34 %) et 15 (21 %) d’entre eux. Un suivi de plus de trois TEP concernait 4 individus (6 %). Le delai median entre la premiere TEP et la deuxieme TEP etait de 6 mois [3–9], et entre la deuxieme et la troisieme de 6,5 mois [5–10]. Au cours des suivis, une elevation du rapport de captation standard, ou standardized uptake value (SUV) de plus de deux points n’a ete mise en evidence que 3 fois. La baisse au cours du temps de la SUV de la TEP n’etait pas significative. Aucune TEP initialement pathologique ne s’est normalisee au cours du suivi. Seuls deux patients avaient une interpretation de la TEP de suivi en faveur d’une recidive d’IPV. Les TEP realisees au-dela d’un an n’apportaient pas de nouveaux diagnostics d’IPV. Conclusion Nos resultats suggerent que la TEP a une place a la fois pour le diagnostic et le suivi des IPVs. Sa sensibilite importante et son caractere non invasif en font un examen de choix permettant probablement des diagnostics plus precoces d’infections chroniques. L’interpretation de la valeur des SUV et un suivi radiologique a plus d’un an est a clarifier.
- Published
- 2020
16. La consultation pré-voyage pour l’Arabie Saoudite : l’occasion d’un rattrapage vaccinal ?
- Author
-
Olivier Robineau, N. Viget, Eric Senneville, Faiza Ajana, B. Lafon-Desmurs, and V. Derdour
- Subjects
Infectious Diseases - Abstract
Introduction Le depart a la Mecque (Hajj/Umra) est un motif recurrent de consultation pre-voyage en centre de vaccination international (CVI) en raison de l’obligation vaccinale anti-meningocoque A, C, Y, W pour l’obtention du visa d’entree en Arabie Saoudite. Cette consultation peut etre l’occasion d’evaluer le statut vaccinal des voyageurs et de proposer une remise a jour vaccinale. Materiels et methodes Etude retrospective monocentrique de 2005 a 2019, portant sur les voyageurs de plus de 18 ans se rendant en Arabie Saoudite. L’analyse du recueil des donnees demographiques, des antecedents vaccinaux et des vaccinations realisees le jour de la consultation a ete realisee. Resultats La consultation a concerne 2520 voyageurs ayant pour projet un voyage en Arabie Saoudite. Le nombre de consultants a triple en 10 ans. L’âge moyen etait de 53,5 ans. Sur les periodes 2005–2009, 2010–2014 et 2015–2019, la proportion de voyageurs de moins 40 ans est passee respectivement de 10,3 % (60/585), a 22,6 % (160/709) a 33,5 % (411/1226) (p Au total, 97,6 % des voyageurs (2461) ont beneficie de la vaccination anti-meningocoque tetravalente, et 2122 (84,2 %) etaient des primovaccines. Un antecedent de vaccination rougeole–oreillons–rubeole (ROR) realise etait renseigne chez 5 % des voyageurs (125) dont 97 % (121) avaient moins de 40 ans. Aucun rattrapage vaccinal ROR n’a ete effectue. La proportion de voyageurs a jour de la vaccination diphterie–tetanos–poliomyelite (DTP) etait de 24,5 % (628) dont 64,3 % (404) avaient plus de 40 ans. Le rattrapage vaccinal a permis la realisation de 223 vaccins DTP, soit 11,7 % des voyageurs non a jour. Un antecedent de vaccination contre l’hepatite B etait retrouve chez 8,3 % (210) dont 61 % (128) avait moins de 40 ans. Seuls 2 schemas vaccinaux contre l’hepatite B ont ete debutes. Concernant l’hepatite A, 30 vaccinations ont ete realisees dont 83 % (25) chez les moins de 40 ans. Conclusion Le nombre de voyageurs a destination de l’Arabie Saoudite est en augmentation et les rites religieux ne sont plus les seuls motifs de voyage. La consultation pre-voyage, si elle est motivee par l’obligation vaccinale anti-meningocoque, est une occasion d’evaluer et de remettre a jour le statut vaccinal des voyageurs vis-a-vis du calendrier vaccinal en vigueur. Ces voyageurs etant de plus en plus jeunes, une attention particuliere a la protection ROR est a porter. Le contexte de couverture vaccinale insuffisante et la concentration de population propre a ce type de voyages, sont des facteurs favorisants connus de la diffusion d’agents pathogenes et de survenues de bouffees epidemiques. Le carnet de vaccination etant souvent manquant, la strategie decisionnelle vaccinale dans ces situations est a developper.
- Published
- 2020
17. Réponse à la lettre de Véronique Barfety-Servignat et Bertrand Lionet
- Author
-
B. Lafon and S. Lorriot
- Subjects
Anesthesiology and Pain Medicine - Published
- 2020
18. Imported malaria in pregnant women: report from a French University Centre
- Author
-
G. Belkadi, B Lafon-Desmurs, Christophe Hennequin, Gilles Pialoux, D. Magne, G. Le Loup, M. Develoux, and E Daray
- Subjects
0301 basic medicine ,Microbiology (medical) ,Adult ,Pediatrics ,medicine.medical_specialty ,Anemia ,030231 tropical medicine ,030106 microbiology ,Asymptomatic ,03 medical and health sciences ,Young Adult ,0302 clinical medicine ,Communicable Diseases, Imported ,Pregnancy ,medicine ,Humans ,Young adult ,Africa South of the Sahara ,Retrospective Studies ,business.industry ,Retrospective cohort study ,General Medicine ,medicine.disease ,Malaria ,Low birth weight ,Infectious Diseases ,Pregnancy Complications, Parasitic ,Chemoprophylaxis ,Female ,France ,medicine.symptom ,business - Abstract
To describe malaria during pregnancy outside endemic areas. We retrospectively reviewed all cases of imported malaria during pregnancy, diagnosed over a 11-year period in a French hospital. We recovered 18 cases, all from sub-Saharan countries. The infection could appear distantly from arrival in France (up to 36 months), was asymptomatic in 3 cases, with anemia being the most common marker of infection (n = 14). The adverse consequences for the fetus (n = 3) or the newborn (n = 4) were frequent. Physicians should be aware of these atypical presentations in order to anticipate the diagnosis and improve the maternal and fetal prognosis.
- Published
- 2017
19. Caractéristiques et pronostic d’une cohorte de patients hospitalisés pour une infection de prothèse vasculaire (IPV) 2000 et 2018
- Author
-
S. Vandamme, A. Pasquet, Michel Valette, O. Robinneau, Olivier Leroy, Eric Senneville, P. D’ellia, and B. Lafon-Desmurs
- Subjects
Infectious Diseases - Abstract
Introduction Decrire les caracteristiques et le pronostic des patients admis pour la prise en charge d’une IPV et evaluer les facteurs associes au deces de ces patients. Materiels et methodes Description de la cohorte prospective de patients suivis pour une IPV dans notre centre entre le 1er janvier 2000 et le 1er fevrier 2018. Les IPV ont ete stratifiees selon la localisation extracavitaire (femoro-femoral, femoro-poplite et axillo-femoral) et intracavitaire du pontage, le delai de survenue precoce (ie Resultats Au total, 200 patients ont ete admis sur la periode. L’âge median des patients etait de 69 ans [IQR : 61–78], il s’agissait principalement d’hommes (86 %). Cent-seize patients avaient une IPV de localisation intracavitaire (58 %), 181 une IPV prouvee (dont 100 precoces). Les enterobacteries et le SAMS etaient les agents pathogenes les plus frequents (n = 60 et 59), suivis des staphylocoques a coagulase negative (n = 30), du streptocoque (n = 26) et de l’enterocoque (n = 25). Les prelevements etaient plurimicrobiens chez 67 patients (34 %) et 102 patients ont pu beneficier d’un remplacement de la prothese infectee (53 %). La mediane de suivi des patients etait de 7,5 mois [IQR : 2–19] durant laquelle 85 patients sont decedes, 41 du fait de l’IPV (21 %) et 30 ont presente un echec (15 %). Les facteurs independamment associes au deces du fait de IPV en analyse multivariee etait : un âge de plus 70 ans (RCa = 8,2 ; p Conclusion Nos resultats suggerent que le pronostique des patients pris en charge pour une IPV depend du site de l’infection, de la survenue d’un choc apres l’admission ; avec un meilleur pronostic chez les patients avec une IPV extracavitaire, sans sepsis. Les IPV ayant beneficiees d’une antibiotherapie associant de la rifampicine etaient de meilleur pronostic.
- Published
- 2018
20. Phaeo-hyphomycose cutanée de l’immunodéprimé : à propos de deux cas
- Author
-
C. Hussenet, G. Monsel, V. Martinez, Eric Caumes, R. Gounot, E. Fourniols, B. Lafon-Desmurs, S. Jaureguiberry, R. Rousseau, R. Calin, A. Fekkar, C. katlama, and I. Meyer
- Subjects
Dermatology - Abstract
Introduction Les champignons du genre Phaeacremonium sp . sont des champignons filamenteux de l’environnement connus pour leur pouvoir phytopathogene. Nous rapportons deux cas de phaeo-hyphomycose a P. krajdenii et P. parasiticum , responsables d’infection cutanee profonde, chez des patients transplantes cardiaques. Observations Le patient 1, 61 ans, d’origine senegalaise, transplante cardiaque depuis 1998, sous prednisone (20 mg/j), mycophenolate mofetil et tacrolimus, hospitalise pour une nocardiose pulmonaire, presentait deux abces de 2 cm (plante et cheville gauche). L’IRM du pied excluait une atteinte osseuse. L’histologie trouvait un granulome necrotique avec des filaments myceliens. La culture obtenait un champignon filamenteux se pigmentant et formant des phialides et conidies. Le sequencage du gene de la beta-tubuline permettait l’identification de P. krajdenii . Les lesions etaient mises a plat chirurgicalement en association a un traitement par voriconazole (400 mg/j) pendant 3 mois permettant la guerison. Le patient 2, 51 ans, martiniquais, transplante cardiaque depuis 3 ans, sous prednisone (10 mg/j), ciclosporine et mycophenolate mofetil, decrivait l’apparition progressive en 2 ans d’une tumefaction sous-cutanee du dos du pied gauche mesurant 5 cm. Le TDM du pied excluait une atteinte osteoarticulaire. La ponction sous-cutanee trouvait de nombreux filaments myceliens septes a l’examen direct. La culture obtenait une moisissure se pigmentant et produisant phialides et conidies. Le sequencage identifiait P. parasiticum . Une exerese chirurgicale complete etait realisee associee a un traitement par voriconazole (400 mg/j) pendant 2 mois aboutissant a la guerison. Discussion Les infections a Phaeocremonium sp. sont rares et principalement opportunistes. Elles sont surtout cutanees (abces sous-cutane, kyste, mycetome) et osteoarticulaires, mais parfois disseminees (fongemie, endocardite). Un seul cas d’infection a P. krajdenii est rapporte dans la litterature, sous la forme d’un mycetome. Nous rapportons ici le premier cas d’abces sous-cutane a P. krajdenii . L’augmentation actuelle de l’incidence des phaeo-hyphomycoses peut etre liee a un sous-diagnostic anterieur du fait de difficultes d’identification du champignon (apport du sequencage pour la classification et l’identification des especes causales) et a l’accroissement du nombre de patients immunodeprimes. En raison de sa rarete, le traitement n’est pas standardise. La chirurgie est privilegiee en cas d’abces. Un antifongique triazole a ete adjoint chez nos 2 patients, adapte a l’antifongigramme, pour prevenir toute dissemination, compte tenu de l’immunodepression. Conclusion Les phaeo-hyphomycoses sont des infections cutanees rares de l’immunodeprime, dont le traitement est chirurgical ou medicochirurgical. L’identification de l’espece par sequencage et l’antifongigramme sont essentiels en particulier chez le patient immunodeprime pour le choix du traitement antifongique.
- Published
- 2015
21. Dermatopolymyosite paranéoplasique avec néphropathie à lésions glomérulaires minimes associée à un lymphome malin non hodgkinien
- Author
-
N. Hajjaji, P. Léturgie, V. Lesire, B Lafon, and J.P. Renard
- Subjects
Gynecology ,medicine.medical_specialty ,Dermatopolymyositis ,business.industry ,Intravenous Immunoglobulins ,Gastroenterology ,Internal Medicine ,Minimal change nephrotic syndrome ,Medicine ,business ,medicine.disease - Abstract
Resume Introduction. – La dermatopolymyosite est une myopathie inflammatoire de cause inconnue. Elle est associee dans 20 a 30 % des cas a un cancer. L’existence d’une atteinte renale est en revanche exceptionnelle. Exegese. – Nous rapportons le cas d’une patiente chez qui la survenue d’une dermatopolymyosite s’est accompagnee successivement d’une glomerulopathie puis d’un lymphome malin non hodgkinien. La patiente a ete traitee initialement par corticotherapie puis, devant le caractere corticoresistant de la dermatomyosite et l’existence d’une atteinte œsophagienne, par immunoglobulines polyvalentes qui ont permis une amelioration significative des signes cutanes et du deficit musculaire. L’amelioration s’est confirmee apres chimiotherapie du lymphome. A neuf mois du diagnostic de dermatopolymyosite, la patiente est consideree en remission de ces deux maladies. Les signes de glomerulopathies ont egalement regresse. Conclusion. – La decouverte d’une dermatopolymyosite impose de rechercher de facon exhaustive un cancer associe. Les donnees de la litterature montrent que celui-ci survient le plus souvent dans la premiere annee suivant le diagnostic de dermatopolymyosite mais qu’il peut egalement se reveler jusqu’a cinq ans apres. Les localisations les plus frequentes sont ovariennes et digestives, mais une meta-analyse recente montre un taux d’incidence standardisee eleve de lymphomes chez des patients atteints de dermatopolymyosite. Les traitement du cancer influence le plus souvent favorablement l’evolution de la dermatopolymyosite. Toutefois, une corticotherapie initiale est toujours indiquee ; l’utilisation des immunoglobulines polyvalentes etant reservee aux formes corticoresistantes ou associees a une atteinte œsophagienne. Enfin, la decouverte d’une nephropathie glomerulaire dans un tel contexte doit faire discuter une glomerulopathie paraneoplasique, une infiltration renale par le lymphome ou encore l’association de la dermatopolymyosite avec une autre connectivite.
- Published
- 2002
22. Un an de prophylaxie pré-exposition (PrEP), la prévention est en marche
- Author
-
M.G. Lebrette, R. Missonnier, B. Lafon-desmurs, L. Lassel, S. Le nagat, Gilles Pialoux, Julie Chas, M.A. Danet, Ana Canestri, and S. Huon
- Subjects
Infectious Diseases - Abstract
Introduction L’efficacite de la PrEP a ete demontree dans de nombreuses etudes et depuis sa mise en place aux Etats-Unis depuis 2012. Peu de donnees sont disponibles, en vie reelle, sur l’evolution sous traitement des comportements sexuels, des ISTs ou des consommations de nouvelles drogues de synthese (chemsex). Materiels et methodes Nous avons mis en place en janvier 2016, immediatement apres la validation de la recommandation temporaire d’utilisation (RTU) par l’ANSM, une approche pluridisciplinaire innovante (medecins, infirmieres et conseillers communautaires) de suivi clinique, d’observance au traitement, et de counseling des patients s’etant presentes pour une initiation de parcours en sante sexuelle au sein d’un service de maladies infectieuses. Les donnees presentees couvrent la premiere annee de suivi. Resultats Trois cent trente-sept personnes ont ete accueillies jusqu’au 5 janvier 2017, 313 ont initie la PrEP (92,9 %). Les raisons de non initiation de PrEP sont : 11 non indications par absence de prise de risque (3,3 %), 5 diagnostics du VIH (1,5 %), 4 pour prises de risque trop recentes avec 3 mises sous traitement post-exposition (0,9 %) et 1 contre-indication (clairance de la creatine Conclusion Au cours de la premiere annee, une seule infection au VIH est observee malgre un taux eleve d’IST asymptomatiques et de consommation de nouvelles drogues de synthese. L’approche multidisciplinaire d’une offre de sante sexuelle renforce la prevention combinee et favorise une notable adhesion au parcours de soin.
- Published
- 2017
23. Effets métaboliques de l'épuration extrarénale continue et discontinue
- Author
-
B Lafon and P Loirat
- Subjects
business.industry ,Medicine ,Critical Care and Intensive Care Medicine ,business - Published
- 1998
24. Syndrome lupique associé à une hépatite induit par la nitrofurantoïne
- Author
-
R. Cevallos, M. Andrejak, J.-P. Ducroix, B Lafon, Denis Chatelain, Amar Smail, and V. Salle
- Subjects
Hepatitis ,medicine.medical_specialty ,Lupus erythematosus ,medicine.diagnostic_test ,business.industry ,Gastroenterology ,MEDLINE ,Follow up studies ,medicine.disease ,Dermatology ,Text mining ,Nitrofurantoin ,Biopsy ,Internal Medicine ,medicine ,business ,Lupus-like syndrome ,medicine.drug - Published
- 2006
25. Experimental measures of human intracranial arteries wall properties
- Author
-
B. Lafon, Franck Jourdan, Dominique Ambard, Omer Eker, Mathieu Sanchez, A. Baldit, and Vincent Costalat
- Subjects
Male ,medicine.medical_specialty ,Biomedical Engineering ,Bioengineering ,Internal medicine ,Occlusion ,medicine ,Cadaver ,Humans ,cardiovascular diseases ,Stroke ,Aged ,business.industry ,Models, Cardiovascular ,Intracranial Artery ,General Medicine ,medicine.disease ,Elasticity ,Computer Science Applications ,Surgery ,Human-Computer Interaction ,Brain vessels ,Cardiology ,Circle of Willis ,Endothelium, Vascular ,business - Abstract
Stroke disease is the main cause of disability in France, with 130,000 cases a year. Most of them are ischemic, secondary to a brain vessel occlusion. Twenty per cent of the strokes are haemorrhagi...
- Published
- 2013
26. MIG-01 - Les mutilations sexuelles féminines : évaluation des connaissances des médecins généralistes et des médecins en consultation du voyage
- Author
-
F. Sorge, Camille Aupiais, B. Lafon-Desmurs, C. Tantet, A. Faye, and D. Lévy
- Subjects
Infectious Diseases - Published
- 2016
27. Place du tubage biliaire dans le diagnostic des pancréatites aiguës sans étiologie retrouvée
- Author
-
J.P. Ducroix, B Lafon, Amar Smail, and J. Baillet
- Subjects
Gynecology ,medicine.medical_specialty ,business.industry ,Gastroenterology ,Internal Medicine ,Medicine ,business - Abstract
Resume Le tubage biliaire intervient dans le diagnostic etiologique des pancreatites aigues lorsque la cause n'est retrouvee ni par l'anamnese, l'examen clinique, les echographies abdominales ou la cholangiographie retrograde. L'etiologie apparait alors liee a la presence de microcristaux biliaires dans 40% des cas. Les microcristaux peuvent etre du monohydrate de cholesterol, du bilirubinate de calcium ou des microspherolithes. Leur seule presence incite a la cholecystectomie pour eviter les recidives de pancreatite aigue.
- Published
- 1994
28. The concept of Cyclic Sound Intensity and its application to acoustical imaging
- Author
-
Menad Sidahmed, B. Lafon, Laurent Polac, Jérôme Antoni, Roberval (Roberval), Université de Technologie de Compiègne (UTC), Laboratoire Vibrations Acoustique (LVA), Institut National des Sciences Appliquées de Lyon (INSA Lyon), Université de Lyon-Institut National des Sciences Appliquées (INSA)-Université de Lyon-Institut National des Sciences Appliquées (INSA), and RENAULT
- Subjects
Engineering ,Acoustics and Ultrasonics ,Property (programming) ,Acoustics ,02 engineering and technology ,7. Clean energy ,01 natural sciences ,law.invention ,symbols.namesake ,0203 mechanical engineering ,law ,0103 physical sciences ,010301 acoustics ,Sound (geography) ,Crankshaft ,[SPI.ACOU]Engineering Sciences [physics]/Acoustics [physics.class-ph] ,geography ,geography.geographical_feature_category ,business.industry ,Mechanical Engineering ,Frame (networking) ,Wiener filter ,Condensed Matter Physics ,Sound intensity ,[PHYS.MECA.ACOU]Physics [physics]/Mechanics [physics]/Acoustics [physics.class-ph] ,Noise ,020303 mechanical engineering & transports ,Mechanics of Materials ,symbols ,business ,Energy (signal processing) - Abstract
International audience; This paper demonstrates how to take advantage of the cyclostationarity property of engine signals to define a new acoustical quantity, the cyclic sound intensity, which displays the instantaneous flux of acoustical energy in the angle-frequency domain during an average engine cycle. This quantity is attractive in that it possesses the ability of being instantaneous and averaged at the same time, thus reconciling two conflicting properties into a rigourous and unambiguous framework. Cyclic sound intensity is a rich concept with several original ramifications. Among other things, it returns a unique decomposition into instantaneous active and reactive parts. Associated to acoustical imaging techniques, it allows the construction of sound radiation movies that evolve within the engine cycle and whose each frame is a sound intensity map calculated at a specific time - or crankshaft angle - in the engine cycle. This enables the accurate localisation of sources in space, in frequency and in time (crankshaft angle). Furthermore, associated to cyclic Wiener filtering, this methodology makes it possible to decompose the overall radiated sound into several noise source contributions whose cyclic sound intensities can then be analysed independently.
- Published
- 2011
29. Acute/Chronic respiratory failure
- Author
-
A. Carneiro, A. Harf, D. Touchard, H. Zar, F. Chamieh, E. Chiner, E. Servera, S. Bouchouha, Michael R. Pinsky, M. Simó, A. Ferretti, J. Blanco, F. Marcier, M. Denis, O. Sychev, G. Conti, E. Salazar, R. Boiteou, M. Belghith, C. Tormo, A. Durocher, H. Hmouda, C. Frostell, C. Aldecoa, M. Tejeda, R. Chacornac, L. Di Chiara, G. Schlag, P. Hernandez, I. Cabezas, S. Iribarren, L. Fakhfakh, J. R. Lancaster, E. Valente, Michael Georgieff, F. Staikowsky, L. Gregorakos, A. Amau, Stewart B. Gottfried, F. Beaufils, C. Santré, S. Nouira, F. Ruiz, A. Bchir, L. Behr, S. Tixier, M. T. Martín, F. Bouvet, C. Núñez, V. Lacueva, N. Bloch, C. Beuscart, C. Katsanos, G. Beaucaire, J. Dall’ava, A. Fatrane, V. Malessios, A. Gursahanev, Michel Aubier, F. Lemaire, L. Tsaldari, L. Brochard, C. Gires, Ph. Dewailly, A. J. Schneider, F. Maltais, R. Traversa, J. Nicoiopoulos, F. Abroug, R. Schiener, J. H. Boix, Yu. Sirenko, D. Dell’Utri, C. Truchero, M. Narváez, Cl. Chastang, A. Peloux, D. Pavlovic, T. Lherm, B. Guidet, A. B. J. Groeneveld, V. Lópes, J. M. Gabillet, V. Cayrel, B. Huet, B. Renaud, A. Fernández, D. Perrin-Gachadoat, A. Herrejón, A. Tenaillon, H. Medaoui, Y. Furet, A. M. Durocher, I. Gültuna, L. Firestone, J. Marin, R. Calvo, H. Romo, M. Sovili, S. Bahrami, J. F. Vaxelaire, H Wiedeck, Apostolos Armaganidis, D. Perrin, J. A. Romand, M. Dambrosio, D. Olivares, B. Lafon, B. Rousset, G. Boussignac, M. Dojat, R. I. C. Wesdorp, V. Parra, N. Gueteau, D. Perrotin, W. Erdmann, Paolo Navalesi, J. Kesecioĝlu, M. Högman, S. Elatrous, G. Diaz-Regañón, J. C. Raphael, O. Leroy, P. Amstutz, F. Brunet, L. G. Thijs, H. Arnberg, F. Pochard, H. Georges, F. Boileau, F. Konrad, H. A. Bruining, J. L. Maravall, T. Vassal, Jean-Paul Mira, C. Mayaud, L. Babiy, J. C. Pompe, C. Ince, J. J. Lanore, P. Marino, G. Hedenstierna, H. Redl, J. Muñoz, A. Diaz-Prieto, Y. Yu, A. Cogliati, P. F. Dequin, F. J. Santos, M. Shchupak, S. Chevret, Ch Martínez, J. Moya, F. Saulnier, H. Hedenström, J. Blanquer, C. Lemaire, I. Hamy, G. Offenstadt, D. Pinquier, R. Boiteau, M. Kountouri, J. F. Dhainaut, F. Salord, C. Brun-Buisson, T. Boulain, J. Castañeda, A. Legras, J. Kilian, M. Jaafoura, and L. Gruez
- Subjects
Acute/chronic respiratory failure ,medicine.medical_specialty ,Continuous Positive Airway Pressure ,Severe Acute Pancreatitis ,business.industry ,Pain medicine ,Critical Care and Intensive Care Medicine ,Pressure Support Ventilation ,Anesthesiology ,Poster Presentation ,Emergency medicine ,Medicine ,business ,Peak Inspiratory Pressure ,Acute Respiratory Failure - Published
- 1992
30. Acute/Chronic respiratory failure II
- Author
-
H. Georges, N. Gueteau, O. Leroy, C. Santré, C. Beuscart, H. Medaoui, C. Lemaire, G. Beaucaire, I. Cabezas, H. Romo, E. Salazar, M. Narváez, D. Pinquier, G. Boussignac, D. Pavlovic, M. Aubier, F. Beaufils, J. C. Raphael, F. Bouvet, S. Chevret, Cl. Chastang, R. Boiteou, T. Lherm, F. Marcier, F. Chamieh, D. Perrin, A. Tenaillon, J. M. Gabillet, B. Guidet, F. Staikowsky, G. Offenstadt, P. Amstutz, C. Truchero, J. Moya, A. Diaz-Prieto, F. Konrad, R. Schiener, J. Kilian, M. Georgieff, F. Salord, V. Cayrel, A. Peloux, S. Tixier, R. Chacornac, A. Durocher, A. M. Durocher, C. Gires, L. Behr, F. Saulnier, L. Gruez, F. Boileau, Ph. Dewailly, H. Wiedeck, R. Boiteau, D. Perrin-Gachadoat, E. Valente, H. Hmouda, A. Fatrane, L. Fakhfakh, N. Bloch, B. Rousset, J. H. Boix, J. Marin, A. Amau, M. Tejeda, D. Olivares, E. Servera, M. Dambrosio, M. Dojat, D. Touchard, A. Harf, F. Lemaire, L. Brochard, C. Tormo, V. Lópes, V. Parra, R. Calvo, V. Lacueva, J. L. Maravall, A. Carneiro, B. Huet, C. Brun-Buisson, A. J. Schneider, A. B. J. Groeneveld, L. G. Thijs, R. I. C. Wesdorp, B. Lafon, M. Denis, T. Vassal, C. Mayaud, M. Högman, H. Hedenström, C. Frostell, H. Arnberg, G. Hedenstierna, J. -A. Romand, M. R. Pinsky, L. Firestone, J. R. Lancaster, H. Zar, F. Brunet, M. Belghith, J. P. Mira, J. J. Lanore, B. Renaud, F. Pochard, J. F. Vaxelaire, I. Hamy, A. Armaganidis, J. Dall’ava, J. F. Dhainaut, P. Navalesi, F. Maltais, A. Gursahanev, P. Hernandez, M. Sovili, S. Gottfried, L. Gregorakos, C. Katsanos, V. Malessios, J. Nicoiopoulos, L. Tsaldari, M. Kountouri, M. T. Martín, F. J. Santos, S. Iribarren, A. Fernández, G. Diaz-Regañón, Ch Martínez, Yu. Sirenko, O. Sychev, M. Shchupak, L. Babiy, J. Muñoz, F. Ruiz, J. Blanquer, M. Simó, A. Herrejón, C. Núñez, E. Chiner, S. Nouira, S. Elatrous, A. Bchir, M. Jaafoura, F. Abroug, S. Bouchouha, S. Bahrami, Y. Yu, H. Redl, G. Schlag, G. Conti, A. Cogliati, D. Dell’Utri, A. Ferretti, R. Traversa, L. Di Chiara, P. Marino, J. Kesecioĝlu, J. C. Pompe, I. Gültuna, C. Ince, W. Erdmann, H. A. Bruining, J. Castañeda, J. Blanco, C. Aldecoa, T. Boulain, Y. Furet, P. F. Dequin, A. Legras, and D. Perrotin
- Subjects
Critical Care and Intensive Care Medicine - Published
- 1992
31. [Paraneoplastic dermatopolymyositis with mild glomerular lesion nephropathy associated with non-Hodgkin's lymphoma]
- Author
-
N, Hajjaji, V, Lesire, P, Leturgie, B, Lafon, and J P, Renard
- Subjects
Diagnosis, Differential ,Glomerulonephritis ,Paraneoplastic Syndromes ,Lymphoma, Non-Hodgkin ,Antineoplastic Combined Chemotherapy Protocols ,Humans ,Female ,Dermatomyositis ,Aged - Abstract
Dermatopolymyositis is an inflammatory disorder of an unknown origin. Twenty to thirty percent cases of this disease are associated with a cancer. Glomerular lesions in dermatopolymyositis are rare.We describe the case of a patient who presented a dermatopolymyositis together with a glomerulopathy and then a non Hodgkin's lymphoma. A treatment by corticoid and secondary intravenous immune globulins because of corticoid-resistance of the dermatopolymyositis and oesophagus injury led to a significant improvement of the cutaneous signs and of the muscular weakness. This favourable evolution was also determined by the chemotherapy for lymphoma. Nine months after the diagnosis of dermatopolymyositis remission for dermatopolymyositis and lymphoma is obtained. We also noticed a regression of the glomerular signs.A diagnosis of dermatopolymyositis must lead to a meticulous search for an associated cancer. Data from literature indicate that a cancer is usually discovered within the first year of dermatopolymyositis' diagnosis but it can appear until five years after this diagnosis. The most frequent organs concerned by cancer are ovary and the digestive tract. A meta-analysis showed an incidence-standardised rate for lymphoma important in patients suffering from dermatopolymyositis. The treatment of the cancer can improve the evolution of the dermatopolymyositis. However corticoid must be the first treatment for dermatopolymyositis. In case of corticoid-resistant dermatopolymyositis or dermatopolymyositis involving oesophagus treatment by intravenous immune globulins is justified. At last when a glomerular nephropathy is discovered in such a situation, paraneoplasic glomerulopathy, renal lymphomatous infiltration or another associated immune disease must be called to mind.
- Published
- 2002
32. [Phenylbutazone-induced sialadenitis fever simulating angioedema]
- Author
-
V, Viseux, L, Béguin, J F, Poulain, A, Sarraj, I, Mayeux, E, Carmi, B, Lafon, and C, Lok
- Subjects
Arthritis, Rheumatoid ,Diagnosis, Differential ,Drug Hypersensitivity ,Phenylbutazone ,Submandibular Gland ,Humans ,Parotid Gland ,Female ,Angioedema ,Middle Aged ,Fever of Unknown Origin ,Sialadenitis - Abstract
Drug-induced sialadenitis is uncommon and unrecognized. Drugs such as nitrofurantoïn, nifedipine and methimazole have been reported to induce sialadenitis. However, phenylbutazone and oxyphenbutazone are the most frequently implicated agents. We describe a case of phenylbutazone-induced parotitis and submaxillitis with cutaneous and hepatic involvement.A 51 year-old woman who had received phenylbutazone for the past 6 days was hospitalized for diagnosis of Quincke's oedema. Clinical examination in fact revealed bilateral parotitis and submaxillitis. The patient had contracted mumps in infancy. Improvement was noticed 8 days after stopping the drug and treatment by glucocorticosteroid. Nevertheless a pruritic eruption with fever appeared. Laboratory data showed leukocytosis with neutrophilia, ESR of 75 mm/hr, hepatic cholestasis and cytolysis. Infectious and autoimmune causes were ruled out. The eruption spontaneously disappeared after 5 days. Laboratory studies 3 weeks later were normal.Quincke's edema diagnosis had been established too fast on "allergic past history" and patient interrogation. Complete clinical examination revealed the correct diagnosis of sialadenitis. This observation shows similarities with other publications: unbearable xerostomia appearing before sialadenitis and with a long course, parotitis with sub-maxillitis, 6 days delay after the first administration of phenylbutazone before fever, local evolution without complication, inflammatory biological syndrome with neutrophilia and absence of infectious cause. Pruritic maculo-papulous eruption and biological hepatic abnormalities are however rare. An hypersensibility mechanism is discussed.
- Published
- 2002
33. [Antibiotic-associated pseudomembranous colitis: retrospective study of 48 cases diagnosed by colonoscopy]
- Author
-
M, Andrejak, B, Lafon, G, Decocq, E, Chetaille, J L, Dupas, J P, Ducroix, and J P, Capron
- Subjects
Adult ,Aged, 80 and over ,Male ,Humans ,Drug Therapy, Combination ,Female ,Colonoscopy ,Middle Aged ,Enterocolitis, Pseudomembranous ,Aged ,Anti-Bacterial Agents ,Retrospective Studies - Abstract
Pseudomembranous colitis (PMC) is a rare but potentially severe complication of antibiotic treatment, which is characterized by the proliferation of the bacterium Clostridium difficile in the colon. In this retrospective study, 48 cases of endoscopically confirmed PMC were included. The following variables were analysed: characteristics of the patients, antibiotics, clinical, biological and endoscopic features of PMC and its treatment. The antibiotic treatment was often ambulatory (83 per cent) for a broncho-pulmonary infection (42 per cent). In 90 per cent of the cases, the treatment included a -lactam, frequently amoxicillin with clavulanic acid, and in 25 per cent of the cases, a fluoroquinolone. The PMC generally occurred after more than 4 days of treatment and was associated with diarrhoea, abdominal pain, fever and rarely vomiting (23 per cent). The complications were hypokalaemia (37 per cent), renal failure (27 per cent) and/or hypoproteinaemia (50 per cent). Pseumembranes were found between the rectum and the left angle of the colon. All patients recovered after one week of oral treatment with metronidazole and/or vancomycin, often in association with Saccharomyces boulardii.
- Published
- 1996
34. [Postpneumonectomy pulmonary edema. Review of the literature. Apropos of 2 new cases]
- Author
-
C, Faisy, B, Bazelly, F, Saïdi, B, Lafon, R, Tordjman, and A, Parrot
- Subjects
Male ,Humans ,Pulmonary Edema ,Middle Aged ,Pneumonectomy ,Prognosis - Abstract
Postpneumonectomy pulmonary edema is a poorly understood clinical entity. We report two new cases and review the literature. The main manifestations are increased pulmonary perfusion flow, endothelial damage, and amputation of the lymphatic system. Treatment depends on the physiological situation of the lung remaining after pneumonectomy. Prevention requires co-operation between the medical and surgical teams.
- Published
- 1996
35. [Role of biliary intubation in the diagnosis of acute pancreatitis without known etiology]
- Author
-
B, Lafon, A, Smail, J P, Ducroix, and J, Baillet
- Subjects
Microscopy ,Pancreatitis ,Acute Disease ,Bile ,Humans ,Crystallization ,Intubation, Gastrointestinal - Abstract
Biliary tubage, is interesting in the aetiological research of acute pancreatitis, when the origin is unknown after anamnesis, clinical examination, abdominal ultrasonographic studies and retrograde cholangiography. The sludge is the aetiology fond in 40% of the cases. Microscopic crystals are either cholesterol monohydrate, either calcium bilirubinate, or calcium carbonate microspheroliths. Biliary microscopic crystals drive the patients to the cholecystectomy to prevent acute pancreatitis relapses.
- Published
- 1994
36. Mechanical ventilation for Pneumocystis carinii pneumonia in patients with the acquired immunodeficiency syndrome. Is the prognosis really improved?
- Author
-
F, Staikowsky, B, Lafon, B, Guidet, M, Denis, C, Mayaud, and G, Offenstadt
- Subjects
Adult ,Male ,Survival Rate ,AIDS-Related Opportunistic Infections ,Pneumonia, Pneumocystis ,Humans ,Female ,Middle Aged ,Prognosis ,Respiratory Insufficiency ,Respiration, Artificial ,Aged ,Retrospective Studies - Abstract
The mortality rate among patients with human immunodeficiency virus (HIV) requiring mechanical ventilation (MV) for acute respiratory failure (ARF) secondary to Pneumocystis carinii pneumonia (PCP) is still a matter of discussion. For some authors, it is in the 50 percent range, while for others the prognosis is grim, with virtually no survivors. The aim of this retrospective study conducted between January 1987 and January 1992 was to analyze the outcome of such patients. We studied 33 patients, 29 men and 4 women (38.6 +/- 9.9 years, 21 homosexuals, 8 intravenous drug users, 3 transfusion related, 1 heterosexual) infected by HIV for at least 19.7 +/- 21.6 months. It was the first PCP episode in all but 2 patients and the diagnosis was made by bronchoalveolar lavage (n = 32) or lung biopsy specimen (n = 1). Only three patients were receiving primary prophylaxis for PCP (trimethoprim-sulfamethoxazole [TMP-SMZ], n = 2; pentamidine, n = 1). Pneumocystis carinii pneumonia was the first manifestation of AIDS in nine patients. The duration of symptoms prior to treatment was 19.6 +/- 11.3 days. At the time of hospital admission, laboratory findings were as follows: PaO2 = 40.7 +/- 7.8 mm Hg on room air; serum LDH = 1,172 +/- 792 IU/L; T4 cell count = 60.2 +/- 67/mm3. Mechanical ventilation was always required for ARF, which was never induced by bronchoscopy. The interval between treatment and MV was 8.1 +/- 6.5 days and the duration of MV was 11.4 +/- 9.9 days. The patients were classified into 3 groups on the basis of the duration and type of treatment before MV, as follows: group 1, n = 10: TMP-SMZ (20-100 mg/kg) IV and methylprednisolone (MP)5 days before MV; group 2, n = 4: TMP-SMZor = 5 days and MP5 days; group 3, n = 19: TMP-SMZ and MPor = 5 days before MV. (The MP dose was as follows: 240 mg/d once a day from day 1 to day 3; 120 mg/d from day 4 to day 6; and 60 mg/d from day 7 to day 9.) Despite MV, TMP-SMZ, and MP, death secondary to PCP-related ARF occurred in 81.9 percent of patients, 20 +/- 4.8 days after the beginning of treatment and 11.4 +/- 9.9 days after the beginning of MV. Six patients survived, five in group 1 and one in group 3.(ABSTRACT TRUNCATED AT 400 WORDS)
- Published
- 1993
37. Efficacy of high-dose intravenous gammaglobulin in the management of acquired von Willebrand's disease during orthopaedic surgery
- Author
-
J. Dieval, B. Roussel, J. C. Capiod, C. Traulle, S. Gross, B. Lafon, J. Delobel, and E. Hayek
- Subjects
Male ,medicine.medical_specialty ,Humeral Fractures ,Intra operative ,Chirurgie orthopedique ,Von Willebrand disease ,medicine ,Coagulopathy ,Humans ,Spinal Neoplasms ,Intraoperative Care ,business.industry ,Immunization, Passive ,Intravenous gammaglobulin ,Hematology ,Humerus ,Middle Aged ,medicine.disease ,Surgery ,Fracture Fixation, Intramedullary ,von Willebrand Diseases ,Acquired von Willebrand's disease ,Orthopedic surgery ,business ,Plasmacytoma - Published
- 1992
38. Une étiologie rare de lésions vertébrales tumorales: la mastocytose systémique
- Author
-
Amar Smail, J.-P. Ducroix, A. Duché, J. Baillet, F. Rammal, and B Lafon
- Subjects
Gastroenterology ,Internal Medicine - Published
- 1997
39. Scorbut et médecine interne
- Author
-
C Traullé, B Lafon, I Leduc, Amar Smail, L Dahmani, KP Tiev, J.-P. Ducroix, and J. Baillet
- Subjects
Gastroenterology ,Internal Medicine - Published
- 1997
40. Hypertension artérielle pulmonaire primitive: un mode rare de révélation du sida. À propos d'une observation
- Author
-
J. Baillet, A. Rudelli, B Lafon, J.-P. Ducroix, A. Duché, Amar Smail, and M.-P. Guillaumont
- Subjects
Gynecology ,medicine.medical_specialty ,biology ,business.industry ,Gastroenterology ,Human immunodeficiency virus (HIV) ,medicine.disease_cause ,biology.organism_classification ,medicine.disease ,Acquired immunodeficiency syndrome (AIDS) ,Immunopathology ,Internal Medicine ,medicine ,Viral disease ,Sida ,business - Published
- 1996
41. Syndrome lupique associé à une hépatite induit par la nitrofurantoïne : à propos d'un cas
- Author
-
R. Cevallos, M. Andrejak, C. Bressolle, B Lafon, Amar Smail, V. Salle, and J.-P. Ducroix
- Subjects
Gastroenterology ,Internal Medicine - Published
- 2001
42. Les pachyméninges médullaires: quelles étiologies rechercher ? Revue de la littérature: à propos de deux cas
- Author
-
J.-P. Ducroix, Amar Smail, C Traullé, I Leduc, J. Baillet, and B Lafon
- Subjects
Gastroenterology ,Internal Medicine - Published
- 1998
43. Régression du lymphome du MALT gastrique localisé, de faible grade histologique de malignité, après traitement éradicateur d'Helicobacter pylori
- Author
-
Jean-Charles Delchier, I Leduc, B Lafon, M Levy, C Traullé, and Christiane Copie-Bergman
- Subjects
Gastroenterology ,Internal Medicine - Published
- 1998
44. Lymphomes des sujets âgés: expérience d'un service de médecine interne
- Author
-
M.N. Guilhaume, J.-P. Ducroix, B Lafon, Amar Smail, J. Baillet, C Traullé, and I Leduc
- Subjects
Gastroenterology ,Internal Medicine - Published
- 1998
45. Un myélome rare: le myélome à IgD. À propos de deux cas
- Author
-
C Traullé, B Lafon, Amar Smail, J. Baillet, I Leduc, and J.-P. Ducroix
- Subjects
Gastroenterology ,Internal Medicine - Published
- 1998
46. Une atteinte surrénalienne rare: le lymphome à grandes cellules
- Author
-
P Bonnard, J. Baillet, J.-P. Ducroix, I Leduc, B Lafon, C Traullé, and Amar Smail
- Subjects
Gastroenterology ,Internal Medicine - Published
- 1998
47. Évaluation de la prise en charge de la douleur dans un service de médecine interne
- Author
-
C Traullé, M.N. Guilhaume, B Lafon, J.-P. Ducroix, KF Tiev, P Tajfel, J. Baillet, I. Dadamessi, I Leduc, and Amar Smail
- Subjects
Gastroenterology ,Internal Medicine - Published
- 1998
48. La candidose grave de l’héroïnomane. À propos d’un cas
- Author
-
J. Baillet, L Dahmani, KP Tiev, C Traullé, J.-P. Ducroix, I Leduc, Amar Smail, and B Lafon
- Subjects
Gastroenterology ,Internal Medicine - Published
- 1997
49. Ténosynovite tuberculeuse
- Author
-
K.P. Tiev, I Leduc, A Smail, I Frossard, B Lafon, J.P. Ducroix, and J Baillet
- Subjects
Gastroenterology ,Internal Medicine - Published
- 1996
50. Enquête prospective sur l'utilisation des antalgiques de niveau II chez les personnes âgées
- Author
-
Amar Smail, B Lafon, C Josse, J. Baillet, J.-P. Ducroix, M Quaillet, and E Serrra
- Subjects
Gastroenterology ,Internal Medicine - Published
- 1996
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.